Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an in-silico approach.
Scientists tested 37 Piper nigrum compounds for lung cancer treatment. Clarkeinol A showed strongest binding to EGFR, with potential as a specific inhibitor with fewer side effects. Further research is warranted.
- Elekofehinti OO et al (2024).
- In Silico Pharmacol.
- PubMed:
- 38601803